Trials / Conditions / Metastatic Sarcoma

Metastatic Sarcoma

22 registered clinical trials studyying Metastatic Sarcoma — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916	Lantheus Medical Imaging	Phase 1 / Phase 2
Recruiting	A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma NCT05835154	Fred Hutchinson Cancer Center	N/A
Recruiting	Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	N/A
Recruiting	Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Re NCT04199026	M.D. Anderson Cancer Center	N/A
Recruiting	Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125	Ann & Robert H Lurie Children's Hospital of Chicago	Phase 1
Recruiting	Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert NCT05711615	National Cancer Institute (NCI)	Phase 1
Unknown	YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma NCT05448820	Tracon Pharmaceuticals Inc.	Phase 1 / Phase 2
Withdrawn	A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas NCT04906876	Brown University	Phase 2
Active Not Recruiting	Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in NCT04595747	National Cancer Institute (NCI)	Phase 2
Recruiting	Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, t NCT04693377	M.D. Anderson Cancer Center	N/A
Recruiting	Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol NCT04771520	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma NCT04457258	Jonsson Comprehensive Cancer Center	EARLY_Phase 1
Active Not Recruiting	Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study NCT04430725	M.D. Anderson Cancer Center	—
Recruiting	Intravital Microscopy in Human Solid Tumors NCT03823144	Mayo Clinic	N/A
Terminated	A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable NCT03520959	Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 3
Completed	Mix Vaccine for Metastatic Sarcoma Patients NCT03357315	Fuda Cancer Hospital, Guangzhou	Phase 1 / Phase 2
Unknown	Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma NCT03168061	NanoCarrier Co., Ltd.	Phase 1 / Phase 2
Completed	A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in NCT02448537	Massachusetts General Hospital	Phase 2
Terminated	Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants Wit NCT02609984	Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	α-TEA in Advanced Cancer NCT02192346	Providence Health & Services	Phase 1
Completed	A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas NCT01112384	NCIC Clinical Trials Group	Phase 2
Completed	Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas NCT01106872	Mohammed M Milhem	Phase 1